WO2020119108A1 - 氢氧舱 - Google Patents
氢氧舱 Download PDFInfo
- Publication number
- WO2020119108A1 WO2020119108A1 PCT/CN2019/095586 CN2019095586W WO2020119108A1 WO 2020119108 A1 WO2020119108 A1 WO 2020119108A1 CN 2019095586 W CN2019095586 W CN 2019095586W WO 2020119108 A1 WO2020119108 A1 WO 2020119108A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hydrogen
- cabin
- air
- concentration
- mixed gas
- Prior art date
Links
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 145
- 239000001257 hydrogen Substances 0.000 claims abstract description 141
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 141
- 239000007789 gas Substances 0.000 claims abstract description 47
- 239000001301 oxygen Substances 0.000 claims description 49
- 229910052760 oxygen Inorganic materials 0.000 claims description 49
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 31
- 238000012806 monitoring device Methods 0.000 claims description 13
- 238000002347 injection Methods 0.000 claims description 8
- 239000007924 injection Substances 0.000 claims description 8
- 238000004891 communication Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000012544 monitoring process Methods 0.000 claims description 2
- 230000003078 antioxidant effect Effects 0.000 abstract description 8
- 239000003963 antioxidant agent Substances 0.000 abstract description 7
- 238000007599 discharging Methods 0.000 abstract 1
- 108010066057 cabin-1 Proteins 0.000 description 37
- 230000029058 respiratory gaseous exchange Effects 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 150000002431 hydrogen Chemical class 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 206010063837 Reperfusion injury Diseases 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 238000004880 explosion Methods 0.000 description 5
- 210000004556 brain Anatomy 0.000 description 4
- 230000009189 diving Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000000554 physical therapy Methods 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 208000031225 myocardial ischemia Diseases 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- 201000006474 Brain Ischemia Diseases 0.000 description 2
- 206010008120 Cerebral ischaemia Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000007954 hypoxia Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000004792 oxidative damage Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000002381 Brain Hypoxia Diseases 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 208000001408 Carbon monoxide poisoning Diseases 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 208000032274 Encephalopathy Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 206010019196 Head injury Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000034486 Multi-organ failure Diseases 0.000 description 1
- 208000010718 Multiple Organ Failure Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 206010033647 Pancreatitis acute Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 206010063897 Renal ischaemia Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000030886 Traumatic Brain injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 201000003229 acute pancreatitis Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 208000009973 brain hypoxia - ischemia Diseases 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 230000010405 clearance mechanism Effects 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000002380 cytological effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 230000009395 genetic defect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000006749 inflammatory damage Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 208000012947 ischemia reperfusion injury Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000029744 multiple organ dysfunction syndrome Diseases 0.000 description 1
- 208000037891 myocardial injury Diseases 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- -1 nitrite anions Chemical class 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61G—TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
- A61G10/00—Treatment rooms or enclosures for medical purposes
- A61G10/02—Treatment rooms or enclosures for medical purposes with artificial climate; with means to maintain a desired pressure, e.g. for germ-free rooms
Definitions
- the invention belongs to the field of health care equipment, and more specifically relates to a hydrogen-oxygen cabin.
- Hydrogen is a colorless, transparent, odorless and tasteless gas.
- the concentration of hydrogen burning in air ranges from 4% to 75%.
- Hydrogen is the smallest density gas known in the world. The density of hydrogen is only 1/14 of that of air. That is, at 0°C and a standard atmospheric pressure, the density of hydrogen is 0.0899g/L. Hydrogen content in the air is extremely low, and it is mainly distributed in the top layer of the atmosphere. Hydrogen is the substance with the smallest relative molecular mass and is mainly used as a reducing agent.
- the early application of hydrogen in medicine was mainly in diving medicine, because hydrogen as a gas for human diving breathing was deeply studied by many important diving medical research units in the world.
- Hydrogen is soluble in water. Under standard conditions, the so-called atmospheric pressure, the solubility of hydrogen at 20 degrees is 1.83%. The solubility of another important gas, oxygen, is 2.4% under standard conditions. Because the solubility of hydrogen is low and it can be diffused arbitrarily in the body, it is usually difficult to maintain hydrogen gas in a certain concentration in the blood by directly inhaling hydrogen or injecting/drinking hydrogen-rich water, resulting in a limited antioxidant effect. Gas solubility is affected by factors such as gas type, pressure, and temperature. For example, at 20°C, the relationship between the solubility of hydrogen in water and the pressure is shown in Figure 5.
- the relationship between the solubility of hydrogen in water and the pressure is basically linear, and each increase in atmospheric pressure can increase the solubility of hydrogen by a factor of two. Therefore, in the human environment, increasing the pressure is an effective way to increase the concentration of dissolved hydrogen.
- the pressurized medium of the high-pressure oxygen cabin is air or medical oxygen.
- the maximum working pressure of air pressurization is not more than 0.3MPa, and the maximum working pressure of oxygen pressurization is not more than 0.2MPa.
- the Chinese utility model patent ZL2015208949170 provides a high-pressure hydrogen tank, including a tank body, an oxygen breathing device provided in the tank body for the user to breathe, a hydrogen source that generates hydrogen and supplies the tank body, and Hydrogen compression device that compresses hydrogen.
- the high-pressure hydrogen tank has at least the following defects:
- the person in the high-pressure hydrogen chamber breathes oxygen, but the entire body is in hydrogen, not the body directly inhales the air containing hydrogen;
- the object of the present invention is to provide a hydrogen-oxygen tank, which solves the problems in the prior art.
- the hydrogen-oxygen cabin disclosed by the present invention includes a cabin, an air source and a hydrogen source.
- the cabin is equipped with an air inlet, a pressure relief part, an opening for human body to enter and exit, and an internal space to accommodate the human body.
- the hydrogen source and air source are mixed to form a mixed gas that can be directly inhaled by the human body.
- the concentration of hydrogen in the mixed gas is less than 4 %, the mixed gas is connected to the air inlet, the air inlet communicates with the interior space of the cabin, and the pressure relief member communicates with the interior space of the cabin to achieve gas discharge in the interior space and maintain the pressure of the interior space below 0.3 MPa.
- the air source is an air injection device, and the air outlet of the air injection device is connected to the air inlet through an air pipe;
- the hydrogen source is a hydrogen generator, and the hydrogen outlet of the hydrogen generator is connected to the air pipe through a hydrogen pipe To achieve the mixing of hydrogen and air.
- Air containing hydrogen has a physiotherapy effect on the human body.
- the air source is an oxygen generator
- the hydrogen source is a hydrogen generator
- the oxygen generator includes an oxygen outlet and an air outlet.
- the oxygen outlet is in communication with the interior space of the cabin, and the air outlet and the air inlet pass through the air.
- the pipelines are connected; the hydrogen outlet of the hydrogen generator is connected to the air pipeline through the hydrogen pipeline to realize the mixing of hydrogen and air to form a mixed gas.
- the increased purity of oxygen and hydrogen has a physiotherapy effect on the human body.
- the pressure relief component includes an automatic pressure relief valve that communicates with the interior space of the cabin.
- the gas pressure of the mixed gas injected into the interior space of the cabin is higher than the safe value of the automatic pressure relief valve, the interior of the cabin The gas in the space can be discharged through the automatic pressure relief valve to stabilize the air pressure in the space inside the cabin and improve the user's comfort.
- the pressure relief component further includes a manual pressure relief valve.
- the manual pressure relief valve communicates with the interior space of the cabin. When a person in the interior space of the cabin feels unwell during use, the manual space relief valve can be used The gas is discharged outward to improve the user's comfort.
- the cabin is a flexible cabin, and a base supporting the flexible cabin is provided at the bottom of the cabin.
- the flexible cabin has a low cost and is also convenient for storage.
- the cabin is a hard cabin, and the hard cabin has a long service life.
- the cabin is provided with a visible area, through which the entire interior space of the cabin can be seen.
- the oxyhydrogen tank further includes a concentration monitoring device and a concentration adjustment device.
- the concentration monitoring device monitors the concentration of hydrogen in the mixed gas.
- the concentration adjustment device is connected to the hydrogen pipeline to control the concentration of hydrogen delivered to the mixed gas.
- the human body can directly inhale the mixed hydrogen-oxygen mixed gas, which is safe and efficient;
- the mixed gas in the cabin can be directly discharged into the air, which is easy to operate and has no safety risks;
- FIG. 1 is a schematic diagram of a module structure of a hydrogen-oxygen cabin according to an embodiment of the present invention
- FIG. 2 is a schematic structural diagram of a hydrogen-oxygen tank according to an embodiment of the present invention.
- FIG. 3 is a schematic structural diagram of a hydrogen-oxygen tank of Embodiment 1 of the present invention.
- FIG. 4 is a schematic structural diagram of a hydrogen-oxygen tank of Embodiment 2 of the present invention.
- Fig. 5 is a schematic diagram of the relationship between the solubility of hydrogen in water and the pressure at 20°C in the background art of the present invention.
- the hydrogen-oxygen cabin disclosed by the present invention includes a cabin 1, an air source 20 and a hydrogen source 21.
- the cabin 1 is provided with an air inlet 10, a pressure relief member 3, an opening 11 for human body access and an internal space 12 containing the human body.
- the hydrogen source 21 and the air source 20 are mixed to form a mixed gas 2 that can be directly inhaled by the human body.
- the concentration of hydrogen in the gas 2 is less than 4%.
- the mixed gas 2 is connected to the air inlet 10, and the air inlet 10 communicates with the internal space 12 of the cabin 1.
- the human body increases a certain amount of hydrogen inhalation in a short time to help the brain relieve fatigue, enhance memory, promote sleep, and then enhance the body's antioxidant capacity and other functions.
- the pressure relief member 3 communicates with the internal space 12 of the cabin 1 to realize gas discharge in the internal space 12 and maintain the pressure of the internal space 12 below 0.3 MPa.
- the pressure relief component 3 includes an automatic pressure relief valve that communicates with the internal space 12 of the cabin 1. When the gas pressure of the mixed gas 2 injected into the internal space 12 of the cabin 1 is higher than the safe value of the automatic pressure relief valve, The gas in the interior space 12 of the cabin 1 can be discharged outward through the automatic pressure relief valve, so that the air pressure in the interior space 12 of the cabin 1 is stabilized, and the safety and comfort of the user are improved.
- the pressure relief component 3 further includes a manual pressure relief valve that communicates with the internal space 12 of the cabin 1 to facilitate the user to adjust the air pressure of the internal space 12 of the cabin 1 by himself. Specifically, when a person in the internal space 12 of the cabin 1 feels unwell during use, the gas in the internal space 12 can be discharged outward through a manual pressure relief valve to improve the user's comfort.
- the cabin 1 may be configured as a flexible cabin, and a base 4 supporting the flexible cabin is provided at the bottom of the cabin 1.
- the connection between the opening 11 and the cabin 1 may be a zipper or an adhesive connection; such a flexible cabin has a low cost and is also convenient for storage.
- the cabin 1 may also be provided as a rigid cabin, and the opening 11 of the rigid cabin may be provided as a door that is pulled outward, and the hard cabin has a long service life.
- the invention is not only suitable for use in hospitals, but also for use in homes and public areas.
- the cabin 1 can also be provided with a visible area 13 through which the entire interior space 12 of the cabin 1 can be seen.
- the visible area 13 of the flexible cabin can be sewn or pasted on the flexible cabin with TPU/PVC transparent materials to facilitate communication between people inside and outside the cabin 1.
- the visible area 13 of the rigid compartment can be mounted on the rigid compartment with transparent glass.
- the purpose of the viewable area 13 is not limited to this. It also has a light-transmitting effect. After the human body enters the internal space 12 of the cabin 1, light enters the internal space 12 of the cabin 1 to improve the human body's comfort in using the hydrogen-oxygen cabin.
- the hydrogen-oxygen tank also includes a concentration monitoring device 6 and a concentration adjustment device 5.
- the concentration monitoring device 6 monitors the concentration of hydrogen in the mixed gas 2.
- the concentration adjustment device 5 is connected to the hydrogen pipeline 215 to control the concentration of hydrogen delivered to the mixed gas 2.
- the present invention provides two embodiments, which are applicable to the flexible cabin and the rigid cabin described in this application.
- the following two embodiments are based on the flexible cabin, and are described in detail as follows.
- the air source 20 is an air injection device, and the air outlet 211 of the air injection device is connected to the air inlet 10 through an air duct 213 to deliver air to the interior of the cabin 1 In space 12.
- the hydrogen source 21 is a hydrogen generator.
- the hydrogen outlet 214 of the hydrogen generator is connected to the air pipe 213 through the hydrogen pipe 215.
- the hydrogen pipe 215 and the air pipe 213 are connected to the air pipe 213 between the air inlet 10 to realize hydrogen. It is mixed with air, and the mixed gas after being mixed is delivered to the internal space 12 of the cabin 1.
- the air containing hydrogen has a physiotherapy effect on the human body and improves the antioxidant capacity of the human body.
- the device for mixing hydrogen and air is not limited to the air duct 213 itself, but can also be replaced by a closed chamber.
- the concentration monitoring device 6 is connected to the air pipe 213 outside the cabin 1 near the air inlet 10, and can monitor the hydrogen concentration of the mixed gas 2 formed by mixing hydrogen and air.
- the concentration adjusting device 5 is connected to the hydrogen pipeline 215.
- the concentration adjusting device 5 may be a regulating valve.
- the concentration monitoring device 6 indicates that the concentration of hydrogen exceeds 4%
- the concentration of hydrogen delivered to the mixed gas 2 may be controlled by the regulating valve.
- the human body enters the internal space 12 of the cabin 1 without any accident.
- the hydrogen concentration is also adjustable, to prevent explosion if the hydrogen concentration is too high, and improve the safety performance of the hydrogen-oxygen cabin.
- the human body increases a certain amount of hydrogen inhalation in a short time to help the brain relieve fatigue, enhance memory, promote sleep, and then enhance the body's antioxidant capacity and other functions.
- the air source 20 is an oxygen generator
- the hydrogen source 21 is a hydrogen generator.
- the oxygen generator includes an oxygen outlet 210 and an air outlet 211, and the oxygen outlet 210 It communicates with the internal space 12 of the cabin 1 through the oxygen pipe 212; the air outlet 211 is connected to the air inlet 10 through the air pipe 213, and the hydrogen gas outlet 214 of the hydrogen generator is connected to the air pipe 213 through the hydrogen pipe 215.
- the air duct 213 between the connection point 215 and the air duct 213 to the air inlet 10 can realize the mixing of hydrogen and air, and deliver the mixed gas after mixing to the interior space 12 of the cabin 1.
- the air containing hydrogen has a physiotherapy effect on the human body.
- the oxygen is also transferred into the internal space 12 and mixed with the air containing hydrogen.
- the purity of the oxygen and hydrogen can be improved to improve the antioxidant capacity of the human body.
- the device for mixing hydrogen and air is not limited to the air duct 213 itself, but can also be replaced by a closed chamber.
- the concentration monitoring device 6 is connected to the air pipe 213 outside the cabin 1 near the air inlet 10, and can monitor the hydrogen concentration of the mixed gas 2 formed by mixing hydrogen and air.
- the concentration adjusting device 5 is connected to the hydrogen pipeline 215.
- the concentration adjusting device 5 may be a regulating valve.
- the concentration monitoring device 6 indicates that the concentration of hydrogen exceeds 4%
- the concentration of hydrogen delivered to the mixed gas 2 may be controlled by the regulating valve.
- the human body enters the internal space 12 of the cabin 1 without any accident.
- the concentration of hydrogen gas is also adjustable, to prevent explosion when the hydrogen gas concentration is too high, and improve the safety performance of the use of the hydrogen-oxygen cabin.
- the human body increases a certain amount of hydrogen inhalation in a short time to help the brain relieve fatigue, enhance memory, promote sleep, and then enhance the body's antioxidant capacity and other functions.
- an additional concentration monitoring device 6 may be provided, which communicates with the interior space 12 of the cabin 1 and can perform a mixed gas 2 formed by mixing hydrogen, oxygen, and air into the interior space 12 of the cabin 1 Hydrogen concentration monitoring.
- the concentration adjusting device 5 is still connected to the hydrogen pipeline 215.
- the concentration adjusting device 5 may be a regulating valve.
- concentration monitoring device 6 shows that the concentration of hydrogen in the cabin 1 exceeds 4%, the hydrogen can be controlled into the mixed gas 2 through the regulating valve. concentration.
- the human body enters the internal space 12 of the cabin 1 without any accident.
- the concentration of hydrogen gas is also adjustable, to prevent explosion when the hydrogen gas concentration is too high, and improve the safety performance of the use of the hydrogen-oxygen cabin.
- the human body can increase the amount of hydrogen and oxygen inhaled in a short time to help the brain relieve fatigue, enhance memory, promote sleep, and then enhance the body's antioxidant capacity and other functions.
- the hydrogen content or oxygen content in the mixed gas 2 described in this application is within a safe level to ensure human safety.
- the hydrogen-oxygen cabin provided by the present invention has a simple structure and is convenient to use, and provides a mixed gas 2 that the human body can directly inhale, which improves the anti-oxidation ability of the human body.
- the concentration monitoring device 6 and the concentration adjusting device 5 can monitor the hydrogen concentration in the mixed gas 2 at any time, and control the concentration of the hydrogen delivered into the mixed gas 2 through the concentration adjusting device 5 according to the situation, so that the cabin 1 can be used more safely.
Landscapes
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Accommodation For Nursing Or Treatment Tables (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (9)
- 氢氧舱,其特征在于,包括舱室、空气源和氢气源,所述舱室设有进气口、泄压部件、供人体出入的开口部和容纳人体的内部空间,所述氢气源和空气源混合后形成可供人体直接吸入的混合气体,所述混合气体中的氢气的浓度小于4%,所述混合气体连接进气口,所述进气口与舱室内部空间连通,所述泄压部件与舱室内部空间连通,实现内部空间中的气体排放,将内部空间的压力维持在0.3MPa以下。
- 根据权利要求1所述的氢氧舱,其特征在于,所述空气源为空气注入装置,所述空气注入装置的空气出气口通过空气管道连接进气口;所述氢气源为制氢装置,所述制氢装置的氢气出气口通过氢气管道与空气管道相连接,实现氢气与空气的混合形成混合气体。
- 根据权利要求1所述的氢氧舱,其特征在于,所述空气源为制氧装置,所述氢气源为制氢装置,所述制氧装置包括氧气出气口和空气出气口,所述氧气出气口与舱室内部空间连通,所述空气出气口与进气口通过空气管道相连接;所述制氢装置的氢气出气口通过氢气管道与空气管道相连接,实现氢气与空气的混合形成混合气体。
- 根据权利要求2或3所述的氢氧舱,其特征在于,所述泄压部件包括自动泄压阀,所述自动泄压阀与舱室内部空间连通,当向舱室内部空间内注入的混合气体的气压高于自动泄压阀的安全数值时,舱室内部空间内的气体可通过自动泄压阀向外排泄,使舱室内部空间的气压稳定。
- 根据权利要求4所述的氢氧舱,其特征在于,所述泄压部件还包括手动泄压阀,所述手动泄压阀与舱室内部空间连通。
- 根据权利要求5所述的氢氧舱,其特征在于,所述舱室为柔性舱室,所述舱室底部设有支撑柔性舱室的底座。
- 根据权利要求5所述的氢氧舱,其特征在于,所述舱室为硬性舱室。
- 根据权利要求6或7所述的氢氧舱,其特征在于,所述舱室设有可视区,通过可视区可看到整个舱室内部空间。
- 根据权利要求2或3所述的氢氧舱,其特征在于,还包括浓度监测装置和浓度调节设备,所述浓度监测装置监测混合气体中氢气的浓度,所述浓度调节设备与氢气管道连接,控制氢气输送到混合气体中的浓度。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811501674.4A CN109394455A (zh) | 2018-12-10 | 2018-12-10 | 氢氧舱 |
CN201811501674.4 | 2018-12-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2020119108A1 true WO2020119108A1 (zh) | 2020-06-18 |
Family
ID=65458147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2019/095586 WO2020119108A1 (zh) | 2018-12-10 | 2019-07-11 | 氢氧舱 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN109394455A (zh) |
WO (1) | WO2020119108A1 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109394455A (zh) * | 2018-12-10 | 2019-03-01 | 云南德林海医疗投资有限公司 | 氢氧舱 |
CN109864865B (zh) * | 2019-03-16 | 2021-04-20 | 宁波中令云途环保技术有限公司 | 一种能充入氢气的增压舱结构 |
CN110742759A (zh) * | 2019-09-30 | 2020-02-04 | 深圳市量子氢生物技术有限公司 | 氢气理疗舱 |
CN112472473A (zh) * | 2020-12-18 | 2021-03-12 | 美魁医疗器械(上海)有限公司 | 一种微高压氢气和氧气舱 |
CN118680779B (zh) * | 2024-06-14 | 2025-03-18 | 广州奥科维电子有限公司 | 一种氢氧舱及控制方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN205144968U (zh) * | 2015-11-11 | 2016-04-13 | 周锋 | 高压氢仓 |
CN205145321U (zh) * | 2015-11-11 | 2016-04-13 | 周锋 | 人体氢气输出设备 |
WO2016176786A1 (de) * | 2015-05-05 | 2016-11-10 | Skan Ag | Dekontaminationsvorrichtung für ein verkehrsmittel |
CN206463307U (zh) * | 2016-07-12 | 2017-09-05 | 周锋 | 一种氢呼吸装置 |
CN109394455A (zh) * | 2018-12-10 | 2019-03-01 | 云南德林海医疗投资有限公司 | 氢氧舱 |
CN109864865A (zh) * | 2019-03-16 | 2019-06-11 | 宁波中令云途环保技术有限公司 | 一种能充入氢气的增压舱结构 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2067463A1 (en) * | 2006-07-25 | 2009-06-10 | Wataru Murota | Hydrogen supply system, and building structure and capsule structure having the system |
JP5612743B1 (ja) * | 2013-09-01 | 2014-10-22 | 河村 隆夫 | 高濃度水素混合ガス呼吸システム |
CN104867025A (zh) * | 2015-06-08 | 2015-08-26 | 杨锦耀 | 一种供人吸取含氢空气或/和氧气的方法及商业模式 |
JP2017046929A (ja) * | 2015-09-02 | 2017-03-09 | 株式会社エアープレス | 水素含有ガス吸入装置及び水素含有ガス吸入装置の動作方法 |
CN204972019U (zh) * | 2015-09-28 | 2016-01-20 | 烟台冰轮高压氧舱有限公司 | 一种高压氧舱生命保障系统 |
JP6029044B1 (ja) * | 2016-03-01 | 2016-11-24 | 株式会社グレイトチレン | 湿式高濃度水素混合ガス呼吸システム |
CN206003359U (zh) * | 2016-06-27 | 2017-03-08 | 首都医科大学附属北京世纪坛医院 | 一种多功能高原环境模拟舱 |
CN106974818B (zh) * | 2017-04-01 | 2019-01-25 | 扬州大学 | 一种整体式氢浴保健设备 |
CN107174445A (zh) * | 2017-06-28 | 2017-09-19 | 上海宝邦医疗器械有限公司 | 硬体式加压氧气舱 |
-
2018
- 2018-12-10 CN CN201811501674.4A patent/CN109394455A/zh active Pending
-
2019
- 2019-07-11 WO PCT/CN2019/095586 patent/WO2020119108A1/zh active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016176786A1 (de) * | 2015-05-05 | 2016-11-10 | Skan Ag | Dekontaminationsvorrichtung für ein verkehrsmittel |
CN205144968U (zh) * | 2015-11-11 | 2016-04-13 | 周锋 | 高压氢仓 |
CN205145321U (zh) * | 2015-11-11 | 2016-04-13 | 周锋 | 人体氢气输出设备 |
CN206463307U (zh) * | 2016-07-12 | 2017-09-05 | 周锋 | 一种氢呼吸装置 |
CN109394455A (zh) * | 2018-12-10 | 2019-03-01 | 云南德林海医疗投资有限公司 | 氢氧舱 |
CN109864865A (zh) * | 2019-03-16 | 2019-06-11 | 宁波中令云途环保技术有限公司 | 一种能充入氢气的增压舱结构 |
Also Published As
Publication number | Publication date |
---|---|
CN109394455A (zh) | 2019-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2020119108A1 (zh) | 氢氧舱 | |
CN204959046U (zh) | 一种安全便携多功能氧氢一体机 | |
CN103785091B (zh) | 保健气体产生系统 | |
CN105063652B (zh) | 一种安全便携多功能氧氢一体机 | |
CN102068743B (zh) | 氢气治疗仪 | |
CN108143566A (zh) | 一种球形多人负氧离子微压氧舱 | |
CN102488951B (zh) | 氢氧呼吸机 | |
CN106334245A (zh) | 一种便携式氢气呼吸机 | |
US20110060257A1 (en) | Gas mist pressure bath system | |
US8517011B2 (en) | Carbon dioxide mist pressure bath system | |
EP2246028A1 (en) | Pressurized carbon dioxide mist bathing system | |
CN109864865B (zh) | 一种能充入氢气的增压舱结构 | |
CN106974818B (zh) | 一种整体式氢浴保健设备 | |
KR100822876B1 (ko) | 구형 고농도 산소캡슐 | |
US20250017799A1 (en) | Mobile Hyperbaric Hydrogen-Oxygen System | |
CN112546377B (zh) | 一种综合型单线态氢氧呼吸机 | |
CN102872553A (zh) | 便捷式全天候化学增氧装置及其使用方法 | |
CN108119684A (zh) | 一种便携式双人微压负氧离子氧舱 | |
CN2894719Y (zh) | 无阻力吸氧接入装置 | |
US20110028889A1 (en) | Gas mist pressure bath system | |
CN202397919U (zh) | 氢氧呼吸机 | |
CN202688070U (zh) | 玉石、大理石净水机 | |
CN116983522A (zh) | 一种带储气囊的氢氧呼吸系统 | |
CN206228721U (zh) | 一种具有辅助吸氧功能的高压氧舱输氧装置 | |
CN203619824U (zh) | 一种移动式高压氧治疗装置 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19896588 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 19896588 Country of ref document: EP Kind code of ref document: A1 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205 DATED 27.01.2022) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 19896588 Country of ref document: EP Kind code of ref document: A1 |